Various studies have reported high MKI67 activity in bronchial dysplastic lesions including 62.5–100% by Wang et al. [36], 1 to 60% by Tan et al. [20, 36], and 49% expression in small cell lung cancer specimens by Paik et al. [36, 38]. This evidence concerns the gene MKI67 and small cell lung carcinoma.